TD Waterhouse Canada’s Asensus Surgical, Inc. ASXC Stock Holding History

TD Waterhouse Canada’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,000	Closed	-$1.33K	–	2044
2024 Q2	$1.33K	Buy	+4,000	New	+$1.08K	﹤0.01%	1704
2024 Q1	–	Sell	-4,000	Closed	-$1.28K	–	1984
2023 Q4	$1.28K	Hold	4,000	–	–	﹤0.01%	1537
2023 Q3	$1.08K	Hold	4,000	–	–	﹤0.01%	1547
2023 Q2	$2K	Hold	4,000	–	–	﹤0.01%	1540
2023 Q1	$2.64K	Hold	4,000	–	–	﹤0.01%	1478
2022 Q4	$1.42K	Hold	4,000	–	–	﹤0.01%	1527
2022 Q3	$1.76K	Hold	4,000	–	–	﹤0.01%	1515
2022 Q2	$1.55K	Hold	4,000	–	–	﹤0.01%	1569
2022 Q1	$2.42K	Hold	4,000	–	–	﹤0.01%	1570
2021 Q4	$4.48K	Buy	+4,000	New	+$6.18K	﹤0.01%	1472

Other funds holding ASXC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TD Waterhouse Canada's ASXC Position: Q3 2024 in Review

TD Waterhouse Canada sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 4,000 shares — an estimated $1.33K sold.

TD Waterhouse Canada first reported a position in ASXC in Q4 2021 and held it in 10 quarters. The position peaked at $4.48K in Q4 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

TD Waterhouse Canada reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
TD Waterhouse Canada sold 4,000 Asensus Surgical, Inc. shares in Q3 2024, an estimated $1.33K.
TD Waterhouse Canada first reported a position in Asensus Surgical, Inc. in Q4 2021 and held it in 10 quarters.
TD Waterhouse Canada's Asensus Surgical, Inc. position peaked at $4.48K in Q4 2021.
1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on TD Waterhouse Canada's 13F filing for Q3 2024, filed 12 Nov 2024.